Skip to main content

Remote Job Finders (RJF)

Collective raises $100M in new funding for AI finops system

Collective raised $100 million in funding, including a $40 million Series B led by General Catalyst, QED, and Gradient Ventures, along with Intuit Ventures, FT Partners, and SemperVirens, plus $60 million from General Catalyst’s Customer Value Fund.

Merck looks ahead to ‘another year of investment’ as Keytruda cliff looms

On its third-quarter earnings investor call Thursday morning, Merck executives touted recent pipeline wins alongside a strong performance for subcutaneous Keytruda and pulmonary arterial hypertension drug Winrevair that drove the pharma’s overall sales expectations to surpass expectations.

BMS drops Prothena-partnered neuro drug, sales outlook improves on a Q3 beat

In addition to canning an Orum-acquired blood cancer candidate last month, Bristol Myers Squibb cut a Prothena-partnered neuro asset in the third quarter. But with sales climbing 7%, the Big Pharma raised its full-year revenue forecast.
Scroll to top